Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study

Authors: Solmaz Sahebjam, Peter A Forsyth, Nam D Tran, John A Arrington, Robert Macaulay, Arnold B Etame, Christine M Walko, Theresa Boyle, Edwin N Peguero, Michael Jaglal, Sepideh Mokhtari, Heiko Enderling, Natarajan Raghunand, Tyra Gatewood, Wendy Long, Jennifer L Dzierzeski, Brittany Evernden, Timothy Robinson, Melissa C Wicklund, Sungjune Kim, Zachary J Thompson, Dung-Tsa Chen, Prakash Chinnaiyan, Hsiang-Hsuan Michael Yu

Published: 2020-11-07

DOI: 10.1093/neuonc/noaa260

Source: Full article

Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study

Abstract